Cargando…
Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model
Targeting human CD2 with the monoclonal antibody (mAb) CB.219 reduces intestinal inflammation in a colitis model where T cells carry human CD2. Here, we asked whether this mAb has adverse effects on infection control. Mice expressing human CD2 on T cells (huCD2tg) were orally infected with Toxoplasm...
Autores principales: | Erben, U., Pawlowski, N. N., Heimesaat, M. M., Loddenkemper, C., Doerfel, K., Spieckermann, S., Siegmund, B., Kühl, A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Akadémiai Kiadó
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681358/ https://www.ncbi.nlm.nih.gov/pubmed/26716019 http://dx.doi.org/10.1556/1886.2015.00040 |
Ejemplares similares
-
Characterization of Chromosomal Instability in Murine Colitis-Associated Colorectal Cancer
por: Gerling, Marco, et al.
Publicado: (2011) -
Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9F1
por: Schrage, Arnhild, et al.
Publicado: (2008) -
Neglected Parasitic Infections in the United States: Toxoplasmosis
por: Jones, Jeffrey L., et al.
Publicado: (2014) -
Toxoplasmosis: Current and Emerging Parasite Druggable Targets
por: Hajj, Rana El, et al.
Publicado: (2021) -
Serum Tyrosine Level in Acute Murine Toxoplasmosis
por: ASGARI, Qasem, et al.
Publicado: (2020)